Approval · Notice of Compliance 10736 · 2009
VISIPAQUE: Notice of Compliance 10736
Issued November 2, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10736
- Date
- November 2, 2009
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To replace sterility test with process parametric release
- Therapeutic class
- Non-ionic radiographic contrast media
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISIPAQUE | Not yet assigned | — |